Role of Insulin Resistance in Non Alcoholic Fatty Liver in Obese Type-2 Diabetic Subjects
Dharmveer Sharma, Sanjeev Kumar Singh, Poonam Gupta, Neelima Singh, Nivedita Singh
Abstract
Dharmveer Sharma, Sanjeev Kumar Singh, Poonam Gupta, Neelima Singh, Nivedita Singh
Abstract
Non alcoholic fatty liver disease (NAFLD) is a fatty liver disease occurring in patients without alcohol consumption. It includes a broad spectrum of liver disease, from fatty infiltration, inflammation and cirrhosis and is associated with obesity, hyperlipidemia and diabetes mellitus.An increase in the BMI and levels of FBS, total cholesterol, triglycerides, HDL, LDL, VLDL, SGPT, ALP, GGT, fasting insulin and hs CRP level and a decrease in HDL was observed in non alcoholic fatty liver group. Obesity, hyperglycemia, dyslipidemia and elevated liver enzymes, fasting insulin and hs CRP level are seen more frequently in non alcoholic fatty liver in type-2 diabetic obese patients.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Non alcoholic fatty liver disease (NAFLD) is a fatty liver disease occurring in patients without alcohol consumption. It includes a broad spectrum of liver disease, from fatty infiltration, inflammation and cirrhosis and is associated with obesity, hyperlipidemia and diabetes mellitus.An increase in the BMI and levels of FBS, total cholesterol, triglycerides, HDL, LDL, VLDL, SGPT, ALP, GGT, fasting insulin and hs CRP level and a decrease in HDL was observed in non alcoholic fatty liver group. Obesity, hyperglycemia, dyslipidemia and elevated liver enzymes, fasting insulin and hs CRP level are seen more frequently in non alcoholic fatty liver in type-2 diabetic obese patients.
Key concepts: Internal medicine, Fatty liver, Insulin resistance, Endocrinology, Dyslipidemia, Medicine, Hyperlipidemia, Type 2 diabetes